Stan Spence

1.4k total citations
23 papers, 748 citations indexed

About

Stan Spence is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stan Spence has authored 23 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stan Spence's work include Birth, Development, and Health (4 papers), Ion channel regulation and function (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Stan Spence is often cited by papers focused on Birth, Development, and Health (4 papers), Ion channel regulation and function (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Stan Spence collaborates with scholars based in United States, Switzerland and United Kingdom. Stan Spence's co-authors include John A. Robson, Chao‐Min Hoe, John B. Coleman, Keith A. Soper, R. S. Eydelloth, Andrew W. Nicholls, W. Scott Argraves, Mark A. Cukierski, Jeremy K. Nicholson and Charles D. Little and has published in prestigious journals such as Blood, Neuroscience and Developmental Biology.

In The Last Decade

Stan Spence

23 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stan Spence United States 14 467 236 84 81 71 23 748
Frank S Ong United States 15 274 0.6× 195 0.8× 35 0.4× 36 0.4× 56 0.8× 21 719
Eduardo López Spain 13 682 1.5× 184 0.8× 25 0.3× 31 0.4× 41 0.6× 17 1.2k
David P. Yarnall United States 15 786 1.7× 65 0.3× 32 0.4× 42 0.5× 187 2.6× 20 1.2k
Beverly Gibson United States 7 502 1.1× 110 0.5× 142 1.7× 24 0.3× 53 0.7× 10 1.3k
F. X. Galen France 16 438 0.9× 437 1.9× 45 0.5× 63 0.8× 52 0.7× 25 840
Normand Brière Canada 11 245 0.5× 110 0.5× 50 0.6× 33 0.4× 51 0.7× 37 591
Z Rymaszewski United States 12 212 0.5× 60 0.3× 27 0.3× 16 0.2× 135 1.9× 28 642
Tamara Ramadan Switzerland 10 361 0.8× 60 0.3× 57 0.7× 36 0.4× 60 0.8× 11 832
Ondrej Juhász United States 13 454 1.0× 203 0.9× 17 0.2× 68 0.8× 36 0.5× 29 822
H Tamaki Japan 18 168 0.4× 28 0.1× 78 0.9× 43 0.5× 93 1.3× 45 800

Countries citing papers authored by Stan Spence

Since Specialization
Citations

This map shows the geographic impact of Stan Spence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Spence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Spence more than expected).

Fields of papers citing papers by Stan Spence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan Spence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Spence. The network helps show where Stan Spence may publish in the future.

Co-authorship network of co-authors of Stan Spence

This figure shows the co-authorship network connecting the top 25 collaborators of Stan Spence. A scholar is included among the top collaborators of Stan Spence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan Spence. Stan Spence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spence, Stan, Mark Deurinck, Haisong Ju, et al.. (2016). Histone Deacetylase Inhibitors Prolong Cardiac Repolarization through Transcriptional Mechanisms. Toxicological Sciences. 153(1). 39–54. 24 indexed citations
2.
Hu, Jing, Sofia Paul, Joanne Schindler, et al.. (2009). Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589).. Blood. 114(22). 2740–2740. 5 indexed citations
3.
Weber, Harald, Feng Tai, Sofia Paul, et al.. (2009). QT Interval Measurements in Patients with Hematologic Malignancies and Solid Tumors Treated with Oral Panobinostat (LBH589).. Blood. 114(22). 3781–3781. 5 indexed citations
4.
Wise, L. David, et al.. (2007). An alternative Alcian Blue dye variant for the evaluation of fetal cartilage. Birth Defects Research Part B Developmental and Reproductive Toxicology. 80(3). 171–176. 13 indexed citations
5.
Wise, L. David, et al.. (2007). Assessment of female and male fertility in Sprague–Dawley rats administered vorinostat, a histone deacetylase inhibitor. Birth Defects Research Part B Developmental and Reproductive Toxicology. 83(1). 19–26. 11 indexed citations
6.
Spence, Stan. (2003). The Dutch‐Belted rabbit: An alternative breed for developmental toxicity testing. Birth Defects Research Part B Developmental and Reproductive Toxicology. 68(5). 439–448. 11 indexed citations
7.
Spence, Stan, William K. Hagmann, Gail Van Riper, et al.. (2002). Effects of VLA‐4 antagonists in rat whole embryo culture. Teratology. 65(1). 26–37. 15 indexed citations
8.
9.
Spence, Stan. (1999). Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reproductive Toxicology. 13(1). 15–29. 46 indexed citations
10.
Spence, Stan. (1998). The Heart Rate-Corrected QT Interval of Conscious Beagle Dogs: A Formula Based on Analysis of Covariance. Toxicological Sciences. 45(2). 247–258. 76 indexed citations
11.
Spence, Stan, et al.. (1996). Toxicokinetic analysis of losartan during gestation and lactation in the rat. Teratology. 53(4). 245–252. 23 indexed citations
12.
Spence, Stan, Henry L. Allen, Mark A. Cukierski, et al.. (1995). Defining the susceptible period of developmental toxicity for the AT1‐selective angiotensin II receptor antagonist Losartan in rats. Teratology. 51(6). 367–382. 54 indexed citations
13.
Wise, L. David, et al.. (1995). Development and Submission of a Nonclinical (Pharmacology/Toxicology) CANDA. Regulatory Toxicology and Pharmacology. 22(1). 46–53. 2 indexed citations
14.
Spence, Stan, et al.. (1995). Effects of Porcine Growth Hormone on Pregnancy and Fetal/Neonatal Development in the Rat. Neonatology. 68(1). 62–74. 3 indexed citations
15.
Spence, Stan, Mark A. Cukierski, Jeanne M. Manson, Richard T. Robertson, & R. S. Eydelloth. (1995). Evaluation of the reproductive and developmental toxicity of the AT1‐selective angiotensin II receptor antagonist Losartan in rats. Teratology. 51(6). 383–397. 22 indexed citations
16.
Spence, Stan & Thomas J. Poole. (1994). Developing blood vessels and associated extracellular matrix as substrates for neural crest migration in Japanese quail, Coturnix coturnix japonica. The International Journal of Developmental Biology. 38(1). 85–98. 23 indexed citations
17.
Spence, Stan, et al.. (1994). Effects of the class III Antiarrhythmic, Dofetilide (UK‐68,798) on the heart rate of midgestation rat embryos, in vitro. Teratology. 49(4). 282–292. 37 indexed citations
18.
Spence, Stan, et al.. (1992). Fibulin is localized at sites of epithelial-mesenchymal transitions in the early avian embryo. Developmental Biology. 151(2). 473–484. 68 indexed citations
19.
Favre, Luc, et al.. (1989). Interaction of oxindanac and frusemide in man. European Journal of Clinical Pharmacology. 37(1). 17–21. 6 indexed citations
20.
Spence, Stan & John A. Robson. (1989). An autoradiographic analysis of neurogenesis in the chick retinain vitro andin vivo. Neuroscience. 32(3). 801–812. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank S Ong Breakdown of academic impact, for papers by Eduardo López Breakdown of academic impact, for papers by David P. Yarnall Breakdown of academic impact, for papers by Beverly Gibson Breakdown of academic impact, for papers by F. X. Galen Breakdown of academic impact, for papers by Normand Brière Breakdown of academic impact, for papers by Z Rymaszewski Breakdown of academic impact, for papers by Tamara Ramadan Breakdown of academic impact, for papers by Ondrej Juhász Breakdown of academic impact, for papers by H Tamaki
Rankless by CCL
2026